Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sven Francque

Showing results (61-70 of 177) with videos related to

Pageof 18
Sort By:
Hepatology (Baltimore, Md.)|December 31, 2013
Prothrombotic factors in histologically proven nonalcoholic fatty liver disease and nonalcoholic steatohepatitisAn Verrijken, Sven Francque, Ilse Mertens, et al.
World Journal of Hepatology|September 26, 2022
Real-life multi-center retrospective analysis on nivolumab in difficult-to-treat patients with advanced hepatocellular carcinomaNika De Wilde, Luisa Vonghia, Sven Francque, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 19, 2016
Noninvasive Detection of Nonalcoholic Steatohepatitis Using Clinical Markers and Circulating Levels of Lipids and MetabolitesYou Zhou, Matej Orešič, Marja Leivonen, et al.
Tropical Medicine & International Health : TM & IH|September 28, 2016
Predictable threats to public health through delaying universal access to innovative medicines for hepatitis C: a pharmaceutical standpointRaffaella Ravinetto, Anja De Weggheleire, Thomas P C Dorlo, et al.
Journal of Hepatology|January 16, 2017
A stepwise algorithm using an at-a-glance first-line test for the non-invasive diagnosis of advanced liver fibrosis and cirrhosisJérôme Boursier, Victor de Ledinghen, Vincent Leroy, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 21, 2009
Non-alcoholic steatohepatitis induces non-fibrosis-related portal hypertension associated with splanchnic vasodilation and signs of a hyperdynamic circulation in vitro and in vivo in a rat modelSven Francque, Sam Wamutu, Shyama Chatterjee, et al.
Acta Clinica Belgica|March 29, 2019
A rare case of hemodialysis-related portosystemic encephalopathy and review of the literatureBarbara Geerinckx, Rachel Hellemans, Amaryllis H Van Craenenbroeck, et al.
Contemporary Clinical Trials|November 16, 2019
A randomized, double-blind, multicenter, phase 2b study to evaluate the safety and efficacy of a combination of tropifexor and cenicriviroc in patients with nonalcoholic steatohepatitis and liver fibrosis: Study design of the TANDEM trialMarcos Pedrosa, Star Seyedkazemi, Sven Francque, et al.
Journal of Hepatology|March 31, 2023
A proposal from the liver forum for the management of comorbidities in non-alcoholic steatohepatitis therapeutic trialsRaluca Pais, Bertrand Cariou, Mazen Noureddin, et al.
Hepatology (Baltimore, Md.)|May 13, 2020
Hepatic Molecular Signatures Highlight the Sexual Dimorphism of Nonalcoholic Steatohepatitis (NASH)Jimmy Vandel, Julie Dubois-Chevalier, Céline Gheeraert, et al.
Pageof 18

Showing results (61-70 of 177) with videos related to

Sort By:
Pageof 18
Hepatology (Baltimore, Md.)|December 31, 2013
Prothrombotic factors in histologically proven nonalcoholic fatty liver disease and nonalcoholic steatohepatitisAn Verrijken, Sven Francque, Ilse Mertens, et al.
World Journal of Hepatology|September 26, 2022
Real-life multi-center retrospective analysis on nivolumab in difficult-to-treat patients with advanced hepatocellular carcinomaNika De Wilde, Luisa Vonghia, Sven Francque, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 19, 2016
Noninvasive Detection of Nonalcoholic Steatohepatitis Using Clinical Markers and Circulating Levels of Lipids and MetabolitesYou Zhou, Matej Orešič, Marja Leivonen, et al.
Tropical Medicine & International Health : TM & IH|September 28, 2016
Predictable threats to public health through delaying universal access to innovative medicines for hepatitis C: a pharmaceutical standpointRaffaella Ravinetto, Anja De Weggheleire, Thomas P C Dorlo, et al.
Journal of Hepatology|January 16, 2017
A stepwise algorithm using an at-a-glance first-line test for the non-invasive diagnosis of advanced liver fibrosis and cirrhosisJérôme Boursier, Victor de Ledinghen, Vincent Leroy, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 21, 2009
Non-alcoholic steatohepatitis induces non-fibrosis-related portal hypertension associated with splanchnic vasodilation and signs of a hyperdynamic circulation in vitro and in vivo in a rat modelSven Francque, Sam Wamutu, Shyama Chatterjee, et al.
Acta Clinica Belgica|March 29, 2019
A rare case of hemodialysis-related portosystemic encephalopathy and review of the literatureBarbara Geerinckx, Rachel Hellemans, Amaryllis H Van Craenenbroeck, et al.
Contemporary Clinical Trials|November 16, 2019
A randomized, double-blind, multicenter, phase 2b study to evaluate the safety and efficacy of a combination of tropifexor and cenicriviroc in patients with nonalcoholic steatohepatitis and liver fibrosis: Study design of the TANDEM trialMarcos Pedrosa, Star Seyedkazemi, Sven Francque, et al.
Journal of Hepatology|March 31, 2023
A proposal from the liver forum for the management of comorbidities in non-alcoholic steatohepatitis therapeutic trialsRaluca Pais, Bertrand Cariou, Mazen Noureddin, et al.
Hepatology (Baltimore, Md.)|May 13, 2020
Hepatic Molecular Signatures Highlight the Sexual Dimorphism of Nonalcoholic Steatohepatitis (NASH)Jimmy Vandel, Julie Dubois-Chevalier, Céline Gheeraert, et al.
Pageof 18